Pitavastatin, also known as the brand name product Livalo, is a lipid-lowering drug belonging to the statin class of medications. By inhibiting the endogenous production of cholesterol within the liver, statins lower abnormal cholesterol and lipid levels and ultimately reduce the risk of cardiovascular disease. It is grouped under the following drug class(es): Cholesterol-reducing agents, Lipid-lowering agents and Statins. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Itavastatin, Pitavastatine and Livalo. Its PubChem CID is 5282452.
Pitavastatin
| CAS No | 147511-69-1 |
|---|---|
| Molecular Formula | C25H24FNO4 |
| Molecular Weight | 421.5 g/mol |
| Synonyms | (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Pitavastatin, also known as the brand name product Livalo, is a lipid-lowering drug belonging to the statin class of medications. By inhibiting the endogenous production of cholesterol within the liver, statins lower abnormal cholesterol and lipid levels and ultimately reduce the risk of cardiovascular disease.
The listed CAS number is 147511-69-1.
The listed molecular formula is C25H24FNO4.
The listed molecular weight is 421.5 g/mol.
(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid.
The source lists Itavastatin, Pitavastatine and Livalo.